Surgical Quality Improvement

Neurosurgery Outcomes

July 2017 – June 2018

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall neurosurgery ACS NSQIP performance benchmarked against 396 participating sites.

Neurosurgery Outcomes (396 Sites) N Observed Expected
30 Day Mortality 889 0.34% 1.26%
30 Day Morbidity 889 6.64% 6.58%
Cardiac 889 1.12% 0.52%
Pneumoniaᵃ 888 0.11% 1.01%
Unplanned Intubation 888 1.01% 1.20%
Ventilator > 48 hours 883 1.13% 0.87%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus 889 1.69% 1.90%
Urinary Tract Infection (UTI) 889 1.01% 1.28%
Surgical Site Infection (SSI) 888 2.48% 1.83%
Sepsisᵇ 879 2.05% 1.05%
Return to Operating Room (ROR) 889 4.05% 3.32%
Readmission 889 6.41% 7.53%

ᵃIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.
ᵇIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.

In addition to overall neurosurgical ACS NSQIP® outcomes data, data specific to spine surgery and brain tumor surgery are provided. Spine surgery performance is benchmarked against 402 participating sites; brain tumor surgery performance is benchmarked against 251 sites.